Add to Watch ListAdd to Watch List Share This PageShare Email This Page Flag This PageFlag
245

SARcode Overview

Edit Overview

SARcode Bioscience, Inc. is a private San Francisco based biopharmaceutical company engaged in the development of a novel class of small molecule lymphocyte function-associated antigen-1 (LFA-1; CD11a/CD18; αLβ2) antagonists as a topical agent for the treatment of significant unmet medical needs in ophthalmology, dermatology and other inflammatory diseases.

2006
Biopharmaceuticals
Biotech Therapeutics
Corporation
Private

Funding

Edit Funding

Date Type Capital Amount Post-Money Valuation Investors
12/31/2007 Series A 7M Unknown
07/2011 Series B 44M Unknown

Products

No product information added yet. Add product information.

Related Companies

Page Information

07/18/2011 04:50PM by limguine

v7 > v6 > v5 > v4 > v3 > v2 > v1 | See all versions

User Opinions

Bulls vs. Bears (0)

Bullish Opinions (0)
Be the first to tell us why they are destined to succeed
Bearish Opinions (0)
Be the first to tell us why they are destined to stumble.
Add your opinion

Add your opinion

Bullish
Bearish

Discussions (0)

Start a New Discussion

Start a New Discussion
Weekly Newsletter

Signup for the VentureBeat Profiles newsletter to receive top news and hot new startups of the week.

Opinion Poll
View All Opinions »
Overall, are you bullish or bearish on SARcode?
vote bullish
vote bearish
Vote to see results or
Alexa Rank: n/a n/a
Yahoo Search Results: n/a  
News & Blogs
View All News »

SARcode Bioscience Gets $44M
Jul 18, 2011 - 0 comments

Clarus Ventures Names Partners
Jan 5, 2009 - 0 comments

SARcode on Twitter
Twitter Search »

There are no discussions right now.

Embed Company Widget
Preview »

Add this company's information to your site.

Recent Contributors

There are no recent contributors to this company.

Related Jobs
loading...